319 related articles for article (PubMed ID: 25754154)
21. Trends in timing of prenatal diagnosis and abortion for fetal chromosomal abnormalities.
Hume H; Chasen ST
Am J Obstet Gynecol; 2015 Oct; 213(4):545.e1-4. PubMed ID: 26070711
[TBL] [Abstract][Full Text] [Related]
22. Single-nucleotide polymorphism-based noninvasive prenatal screening in a high-risk and low-risk cohort.
Pergament E; Cuckle H; Zimmermann B; Banjevic M; Sigurjonsson S; Ryan A; Hall MP; Dodd M; Lacroute P; Stosic M; Chopra N; Hunkapiller N; Prosen DE; McAdoo S; Demko Z; Siddiqui A; Hill M; Rabinowitz M
Obstet Gynecol; 2014 Aug; 124(2 Pt 1):210-218. PubMed ID: 25004354
[TBL] [Abstract][Full Text] [Related]
23. Size-based molecular diagnostics using plasma DNA for noninvasive prenatal testing.
Yu SC; Chan KC; Zheng YW; Jiang P; Liao GJ; Sun H; Akolekar R; Leung TY; Go AT; van Vugt JM; Minekawa R; Oudejans CB; Nicolaides KH; Chiu RW; Lo YM
Proc Natl Acad Sci U S A; 2014 Jun; 111(23):8583-8. PubMed ID: 24843150
[TBL] [Abstract][Full Text] [Related]
24. The impact of first trimester screening and early fetal anomaly scan on invasive testing rates in women with advanced maternal age.
Hagen A; Entezami M; Gasiorek-Wiens A; Albig M; Becker R; Knoll U; Stumm M; Wegner RD
Ultraschall Med; 2011 Jun; 32(3):302-6. PubMed ID: 20972947
[TBL] [Abstract][Full Text] [Related]
25. Access to prenatal cytogenetic diagnosis in Catania: a retrospective survey.
Agodi A; Barchitta M; Quattrocchi A; Corallo T; Venticinque V; Caruso M
Ann Ig; 2013; 25(6):529-37. PubMed ID: 24284539
[TBL] [Abstract][Full Text] [Related]
26. First-trimester screening for trisomies 18 and 13, triploidy and Turner syndrome by detailed early anomaly scan.
Wagner P; Sonek J; Hoopmann M; Abele H; Kagan KO
Ultrasound Obstet Gynecol; 2016 Oct; 48(4):446-451. PubMed ID: 26611869
[TBL] [Abstract][Full Text] [Related]
27. Implementation of non-invasive prenatal testing by semiconductor sequencing in a genetic laboratory.
Dheedene A; Sante T; De Smet M; Vanbellinghen JF; Grisart B; Vergult S; Janssens S; Menten B
Prenat Diagn; 2016 Aug; 36(8):699-707. PubMed ID: 27176606
[TBL] [Abstract][Full Text] [Related]
28. Prenatal diagnosis and molecular cytogenetic characterization of a mosaic derivative Y chromosome derived from a de novo unbalanced reciprocal Yq;13q translocation.
Chen CP; Su YN; Chen M; Huang JP; Tsai FJ; Wu PC; Chen WL; Wang W
Taiwan J Obstet Gynecol; 2011 Sep; 50(3):394-8. PubMed ID: 22030064
[No Abstract] [Full Text] [Related]
29. Beyond the first trimester screen: can we predict who will choose invasive testing?
van Landingham S; Bienstock J; Wood Denne E; Hueppchen N
Genet Med; 2011 Jun; 13(6):539-44. PubMed ID: 21415760
[TBL] [Abstract][Full Text] [Related]
30. [Noninvasive prenatal diagnosis of trisomy 21, 18 and 13 using cell-free fetal DNA].
Gorzelnik K; Bijok J; Zimowski JG; Jakiel G; Roszkowski T
Ginekol Pol; 2013 Aug; 84(8):714-9. PubMed ID: 24191506
[TBL] [Abstract][Full Text] [Related]
31. Clinical evaluation of the IONA test: a non-invasive prenatal screening test for trisomies 21, 18 and 13.
Papageorghiou AT; Khalil A; Forman M; Hulme R; Mazey R; Mousa HA; Johnstone ED; McKelvey A; Cohen KE; Risley M; Denman W; Kelly B
Ultrasound Obstet Gynecol; 2016 Feb; 47(2):188-93. PubMed ID: 26493543
[TBL] [Abstract][Full Text] [Related]
32. Prenatal diagnosis of trisomy 21, 18 and 13 by quantitative pyrosequencing of segmental duplications.
Tong H; Jin Y; Xu Y; Zou B; Ye H; Wu H; Kumar S; Pitman JL; Zhou G; Song Q
Clin Genet; 2016 Nov; 90(5):451-455. PubMed ID: 26948280
[TBL] [Abstract][Full Text] [Related]
33. Use of cell-free fetal DNA in maternal plasma for noninvasive prenatal screening.
Wagner AJ; Mitchell ME; Tomita-Mitchell A
Clin Perinatol; 2014 Dec; 41(4):957-66. PubMed ID: 25459783
[TBL] [Abstract][Full Text] [Related]
34. Systematic review of noninvasive prenatal diagnosis for abnormal chromosome genetic diseases using free fetal DNA in maternal plasma.
Yang H; Xu HB; Liu TT; He XL
Genet Mol Res; 2015 Sep; 14(3):10603-8. PubMed ID: 26400291
[TBL] [Abstract][Full Text] [Related]
35. Noninvasive prenatal testing (NIPT) in twin pregnancies with treatment of assisted reproductive techniques (ART) in a single center.
Tan Y; Gao Y; Lin G; Fu M; Li X; Yin X; Du J; Li J; Li W; Peng H; Yuan Y; Chen F; Jiang F; Zhang H; Lu G; Gong F; Wang W
Prenat Diagn; 2016 Jul; 36(7):672-9. PubMed ID: 27150972
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of non-invasive prenatal testing (NIPT) for aneuploidy in an NHS setting: a reliable accurate prenatal non-invasive diagnosis (RAPID) protocol.
Hill M; Wright D; Daley R; Lewis C; McKay F; Mason S; Lench N; Howarth A; Boustred C; Lo K; Plagnol V; Spencer K; Fisher J; Kroese M; Morris S; Chitty LS
BMC Pregnancy Childbirth; 2014 Jul; 14():229. PubMed ID: 25027965
[TBL] [Abstract][Full Text] [Related]
37. Detection of mosaicism for primary trisomies in prenatal samples by QF-PCR and karyotype analysis.
Donaghue C; Mann K; Docherty Z; Ogilvie CM
Prenat Diagn; 2005 Jan; 25(1):65-72. PubMed ID: 15662691
[TBL] [Abstract][Full Text] [Related]
38. First-trimester contingent screening for trisomies 21, 18 and 13 by biomarkers and maternal blood cell-free DNA testing.
Nicolaides KH; Syngelaki A; Poon LC; Gil MM; Wright D
Fetal Diagn Ther; 2014; 35(3):185-92. PubMed ID: 24192489
[TBL] [Abstract][Full Text] [Related]
39. IONA test for first-trimester detection of trisomies 21, 18 and 13.
Poon LC; Dumidrascu-Diris D; Francisco C; Fantasia I; Nicolaides KH
Ultrasound Obstet Gynecol; 2016 Feb; 47(2):184-7. PubMed ID: 26387684
[TBL] [Abstract][Full Text] [Related]
40. Fetal aneuploidy screening with cell-free DNA in late gestation.
Taneja PA; Prosen TL; de Feo E; Kruglyak KM; Halks-Miller M; Curnow KJ; Bhatt S
J Matern Fetal Neonatal Med; 2017 Feb; 30(3):338-342. PubMed ID: 27124739
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
